Annual EBITDA
-$16.82 M
-$5.87 M-53.57%
December 31, 2021
Summary
- As of February 10, 2025, CYRN annual EBITDA is -$16.82 million, with the most recent change of -$5.87 million (-53.57%) on December 31, 2021.
- During the last 3 years, CYRN annual EBITDA has fallen by -$3.41 million (-25.42%).
Performance
CYRN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$4.90 M
-$96.00 K-2.00%
September 30, 2022
Summary
- As of February 10, 2025, CYRN quarterly EBITDA is -$4.90 million, with the most recent change of -$96.00 thousand (-2.00%) on September 30, 2022.
- Over the past year, CYRN quarterly EBITDA has dropped by -$707.00 thousand (-16.86%).
Performance
CYRN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$17.53 M
-$707.00 K-4.20%
September 30, 2022
Summary
- As of February 10, 2025, CYRN TTM EBITDA is -$17.53 million, with the most recent change of -$707.00 thousand (-4.20%) on September 30, 2022.
- Over the past year, CYRN TTM EBITDA has dropped by -$1.31 million (-8.08%).
Performance
CYRN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CYRN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.6% | -16.9% | -8.1% |
| 3 y3 years | -25.4% | -218.4% | -48.5% |
| 5 y5 years | -103.6% | -125.3% | -48.5% |
CYRN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +83.1% | +5.0% | +23.3% | at low |
| 5 y | 5-year | +53.6% | at low | +243.4% | +5.0% | +75.8% | at low |
| alltime | all time | -446.2% | +91.6% | -153.0% | +391.8% | -379.2% | +187.8% |
Cyren EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$4.90 M(+2.0%) | -$17.53 M(+4.2%) |
| Jun 2022 | - | -$4.80 M(-6.7%) | -$16.82 M(+0.9%) |
| Mar 2022 | - | -$5.15 M(+92.3%) | -$16.68 M(+17.3%) |
| Dec 2021 | -$16.82 M(+53.6%) | -$2.68 M(-36.2%) | -$14.22 M(-12.3%) |
| Sep 2021 | - | -$4.19 M(-9.9%) | -$16.22 M(+11.3%) |
| Jun 2021 | - | -$4.66 M(+72.8%) | -$14.57 M(+21.4%) |
| Mar 2021 | - | -$2.69 M(-42.4%) | -$12.00 M(+11.8%) |
| Dec 2020 | -$10.95 M(-7.7%) | -$4.68 M(+83.6%) | -$10.74 M(-2.2%) |
| Sep 2020 | - | -$2.55 M(+22.0%) | -$10.98 M(+10.1%) |
| Jun 2020 | - | -$2.09 M(+46.3%) | -$9.97 M(-5.1%) |
| Mar 2020 | - | -$1.43 M(-71.0%) | -$10.51 M(-11.0%) |
| Dec 2019 | -$11.86 M(-11.5%) | -$4.92 M(+219.5%) | -$11.81 M(+7.9%) |
| Sep 2019 | - | -$1.54 M(-41.3%) | -$10.94 M(-12.1%) |
| Jun 2019 | - | -$2.62 M(-3.7%) | -$12.44 M(+1.0%) |
| Mar 2019 | - | -$2.73 M(-32.7%) | -$12.31 M(-8.2%) |
| Dec 2018 | -$13.41 M(+62.3%) | -$4.05 M(+33.1%) | -$13.41 M(+6.1%) |
| Sep 2018 | - | -$3.04 M(+21.9%) | -$12.64 M(+7.4%) |
| Jun 2018 | - | -$2.50 M(-34.7%) | -$11.77 M(+12.6%) |
| Mar 2018 | - | -$3.82 M(+16.7%) | -$10.45 M(+33.8%) |
| Dec 2017 | -$8.26 M(+291.0%) | -$3.28 M(+50.6%) | -$7.81 M(+43.6%) |
| Sep 2017 | - | -$2.17 M(+84.9%) | -$5.44 M(+80.4%) |
| Jun 2017 | - | -$1.18 M(-0.7%) | -$3.02 M(+102.6%) |
| Mar 2017 | - | -$1.18 M(+31.0%) | -$1.49 M(+58.6%) |
| Dec 2016 | -$2.11 M(+40.7%) | -$904.00 K(-463.1%) | -$938.00 K(+212.7%) |
| Sep 2016 | - | $249.00 K(-29.1%) | -$300.00 K(-74.5%) |
| Jun 2016 | - | $351.00 K(-155.4%) | -$1.18 M(-16.3%) |
| Mar 2016 | - | -$634.00 K(+138.3%) | -$1.41 M(-6.3%) |
| Dec 2015 | -$1.50 M(-60.0%) | -$266.00 K(-57.7%) | -$1.50 M(-50.1%) |
| Sep 2015 | - | -$629.00 K(-619.8%) | -$3.01 M(+43.3%) |
| Jun 2015 | - | $121.00 K(-116.6%) | -$2.10 M(-37.0%) |
| Mar 2015 | - | -$728.00 K(-59.0%) | -$3.34 M(-11.1%) |
| Dec 2014 | -$3.76 M(+140.3%) | -$1.78 M(-730.1%) | -$3.76 M(+8.1%) |
| Sep 2014 | - | $282.00 K(-125.3%) | -$3.47 M(+5.1%) |
| Jun 2014 | - | -$1.11 M(-2.7%) | -$3.31 M(+45.8%) |
| Mar 2014 | - | -$1.15 M(-23.3%) | -$2.27 M(+40.8%) |
| Dec 2013 | -$1.56 M(-177.8%) | -$1.50 M(-432.2%) | -$1.61 M(+156.0%) |
| Sep 2013 | - | $450.00 K(-692.1%) | -$629.00 K(-16.9%) |
| Jun 2013 | - | -$76.00 K(-84.5%) | -$757.00 K(-553.3%) |
| Mar 2013 | - | -$489.00 K(-4.9%) | $167.00 K(-91.7%) |
| Dec 2012 | $2.01 M(-58.6%) | -$514.00 K(-259.6%) | $2.01 M(-41.1%) |
| Sep 2012 | - | $322.00 K(-62.0%) | $3.41 M(-23.9%) |
| Jun 2012 | - | $848.00 K(-37.3%) | $4.48 M(-12.1%) |
| Mar 2012 | - | $1.35 M(+52.4%) | $5.10 M(+5.0%) |
| Dec 2011 | $4.86 M(+20.3%) | $888.00 K(-36.3%) | $4.86 M(-1.5%) |
| Sep 2011 | - | $1.39 M(-4.9%) | $4.93 M(+7.8%) |
| Jun 2011 | - | $1.47 M(+32.1%) | $4.58 M(+8.6%) |
| Mar 2011 | - | $1.11 M(+15.4%) | $4.21 M(+4.4%) |
| Dec 2010 | $4.04 M | $962.00 K(-7.2%) | $4.04 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $1.04 M(-6.2%) | $4.14 M(+5.5%) |
| Jun 2010 | - | $1.10 M(+18.3%) | $3.93 M(+8.1%) |
| Mar 2010 | - | $934.00 K(-12.6%) | $3.63 M(+9.1%) |
| Dec 2009 | $3.33 M(+39.0%) | $1.07 M(+30.2%) | $3.33 M(+11.7%) |
| Sep 2009 | - | $821.00 K(+1.2%) | $2.98 M(+5.9%) |
| Jun 2009 | - | $811.00 K(+28.3%) | $2.82 M(+6.9%) |
| Mar 2009 | - | $632.00 K(-12.2%) | $2.64 M(+10.0%) |
| Dec 2008 | $2.40 M(+19.4%) | $720.00 K(+9.8%) | $2.40 M(-0.7%) |
| Sep 2008 | - | $656.00 K(+4.5%) | $2.41 M(+1.2%) |
| Jun 2008 | - | $628.00 K(+59.8%) | $2.38 M(+11.3%) |
| Mar 2008 | - | $393.00 K(-46.6%) | $2.14 M(+6.7%) |
| Dec 2007 | $2.01 M(-1074.3%) | $736.00 K(+17.2%) | $2.01 M(+49.6%) |
| Sep 2007 | - | $628.00 K(+63.1%) | $1.34 M(+71.2%) |
| Jun 2007 | - | $385.00 K(+49.2%) | $784.00 K(+212.4%) |
| Mar 2007 | - | $258.00 K(+263.4%) | $251.00 K(-160.5%) |
| Dec 2006 | -$206.00 K(-69.1%) | $71.00 K(+1.4%) | -$415.00 K(-57.2%) |
| Sep 2006 | - | $70.00 K(-147.3%) | -$969.00 K(+0.5%) |
| Jun 2006 | - | -$148.00 K(-63.7%) | -$964.00 K(+2.1%) |
| Mar 2006 | - | -$408.00 K(-15.5%) | -$944.00 K(+4.3%) |
| Dec 2005 | -$666.00 K(-89.2%) | -$483.00 K(-744.0%) | -$905.00 K(-45.8%) |
| Sep 2005 | - | $75.00 K(-158.6%) | -$1.67 M(-51.8%) |
| Jun 2005 | - | -$128.00 K(-65.3%) | -$3.47 M(-30.9%) |
| Mar 2005 | - | -$369.00 K(-70.5%) | -$5.02 M(-18.9%) |
| Dec 2004 | -$6.19 M(+92.4%) | -$1.25 M(-27.4%) | -$6.19 M(+1.5%) |
| Sep 2004 | - | -$1.72 M(+2.4%) | -$6.10 M(+2.0%) |
| Jun 2004 | - | -$1.68 M(+9.0%) | -$5.98 M(+10.6%) |
| Mar 2004 | - | -$1.54 M(+33.3%) | -$5.41 M(+10.1%) |
| Dec 2003 | -$3.22 M(+7.0%) | -$1.16 M(-27.8%) | -$4.91 M(-15.1%) |
| Sep 2003 | - | -$1.60 M(+44.8%) | -$5.78 M(+15.0%) |
| Jun 2003 | - | -$1.11 M(+6.0%) | -$5.03 M(+11.3%) |
| Mar 2003 | - | -$1.04 M(-48.6%) | -$4.52 M(-9.6%) |
| Dec 2002 | -$3.01 M(-90.7%) | -$2.03 M(+139.1%) | -$5.00 M(-179.6%) |
| Sep 2002 | - | -$849.00 K(+42.4%) | $6.28 M(-137.0%) |
| Jun 2002 | - | -$596.00 K(-60.8%) | -$16.97 M(-20.6%) |
| Mar 2002 | - | -$1.52 M(-116.5%) | -$21.37 M(-35.7%) |
| Dec 2001 | -$32.22 M(+7.4%) | $9.25 M(-138.4%) | -$33.25 M(-34.1%) |
| Sep 2001 | - | -$24.10 M(+382.9%) | -$50.45 M(+46.5%) |
| Jun 2001 | - | -$4.99 M(-62.8%) | -$34.44 M(-7.5%) |
| Mar 2001 | - | -$13.40 M(+68.7%) | -$37.23 M(+24.0%) |
| Dec 2000 | -$30.01 M(+146.0%) | -$7.95 M(-1.8%) | -$30.01 M(+12.1%) |
| Sep 2000 | - | -$8.09 M(+4.0%) | -$26.78 M(+17.6%) |
| Jun 2000 | - | -$7.79 M(+25.8%) | -$22.77 M(+32.9%) |
| Mar 2000 | - | -$6.19 M(+31.3%) | -$17.13 M(+40.5%) |
| Dec 1999 | -$12.20 M(+281.3%) | -$4.71 M(+15.5%) | -$12.20 M(+63.0%) |
| Sep 1999 | - | -$4.08 M(+90.2%) | -$7.48 M(+120.1%) |
| Jun 1999 | - | -$2.15 M(+71.2%) | -$3.40 M(+171.2%) |
| Mar 1999 | - | -$1.25 M | -$1.25 M |
| Dec 1998 | -$3.20 M | - | - |
FAQ
- What is Cyren annual EBITDA?
- What is the all time high annual EBITDA for Cyren?
- What is Cyren annual EBITDA year-on-year change?
- What is Cyren quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cyren?
- What is Cyren quarterly EBITDA year-on-year change?
- What is Cyren TTM EBITDA?
- What is the all time high TTM EBITDA for Cyren?
- What is Cyren TTM EBITDA year-on-year change?
What is Cyren annual EBITDA?
The current annual EBITDA of CYRN is -$16.82 M
What is the all time high annual EBITDA for Cyren?
Cyren all-time high annual EBITDA is $4.86 M
What is Cyren annual EBITDA year-on-year change?
Over the past year, CYRN annual EBITDA has changed by -$5.87 M (-53.57%)
What is Cyren quarterly EBITDA?
The current quarterly EBITDA of CYRN is -$4.90 M
What is the all time high quarterly EBITDA for Cyren?
Cyren all-time high quarterly EBITDA is $9.25 M
What is Cyren quarterly EBITDA year-on-year change?
Over the past year, CYRN quarterly EBITDA has changed by -$707.00 K (-16.86%)
What is Cyren TTM EBITDA?
The current TTM EBITDA of CYRN is -$17.53 M
What is the all time high TTM EBITDA for Cyren?
Cyren all-time high TTM EBITDA is $6.28 M
What is Cyren TTM EBITDA year-on-year change?
Over the past year, CYRN TTM EBITDA has changed by -$1.31 M (-8.08%)